Accord started commercial marketing activities in August 2008. Pan European coverage has been rapidly attained. As of 2013 Accord products have been sold in over 30 European markets.

Since beginning our commercial activities we have shipped over one hundred and fifty million packs of pharmaceuticals (equating to over 5 billion doses) within Europe bringing benefit to millions of patients.    

To date Accord has gained nearly 5000 product approvals across the European Economic Area and we are actively working on extending this number, so more patients can benefit from our products in the future.